Literature DB >> 434065

The clinical course of serpiginous choroidopathy.

H Weiss, W H Annesley, J A Shields, T Tomer, K Christopherson.   

Abstract

We closely observed nine patients (17 eyes) with serpiginous choroidopathy for time periods ranging from two to ten years. There were seven men and two women with ages ranging from 22 to 58 years, average age was 46 years. Eight patients were bilaterally affected; one patient had only one eye. The clinical course of the disease was characterized by multiple recurrences. The recurrences and progression of the disease often were not noticed by patients if the macular area was not involved. Serial fundus photographs proved to be invaluable in establishing progression. Although the disease usually progresses in a centrifugal manner from the disk toward the periphery, three patients demonstrated centripetal progression and one of these three permanently lost central acuity. Visual acuity was affected only when the foveal or parafoveal areas became involved, but in nine of the 17 eyes, visual acuity returned to a variable degree. None of the patients had any general systemic illness. However, five of the patients reported chronic exposure to an unusual variety of chemicals.

Entities:  

Mesh:

Year:  1979        PMID: 434065     DOI: 10.1016/0002-9394(79)90131-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  Cyclosporine-A in the treatment of serpiginous choroiditis.

Authors:  A G Secchi; M S Tognon; C Maselli
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Retinal function in patients with serpiginous choroiditis: a microperimetry study.

Authors:  Elisabetta Pilotto; Stela Vujosevic; Vuga Ana Grgic; Patrik Sportiello; Enrica Convento; Antonio Giovanni Secchi; Edoardo Midena
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-13       Impact factor: 3.117

3.  Juvenile atrophy of pigment epithelium and choriocapillaris.

Authors:  C Hoyng; A Pinckers; A Deutman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 4.  The possible impact of uveitis in blindness: a literature survey.

Authors:  M S Suttorp-Schulten; A Rothova
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

Review 5.  Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

Authors:  Hossein Nazari Khanamiri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2013-03-27       Impact factor: 6.048

6.  Indocyanine green angiographic findings in serpiginous choroidopathy.

Authors:  A Giovannini; C Mariotti; E Ripa; B Scassellati-Sforzolini
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

7.  Causes and frequency of blindness in patients with intraocular inflammatory disease.

Authors:  A Rothova; M S Suttorp-van Schulten; W Frits Treffers; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

8.  Persistent placoid maculopathy: a new clinical entity.

Authors:  Pamela R Golchet; Lee M Jampol; David Wilson; Lawrence A Yannuzzi; Michael Ober; Edward Stroh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Subretinal and disc neovascularisation in serpiginous choroiditis.

Authors:  L Laatikainen; H Erkkilä
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.